Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y B Cho

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Anticancer Research|May 1, 1996
Pharmacokinetics of a new platinum compound, cis-(glycolato-O,O) [(4R,5R)-4,5-bis(aminomethyl)-1,3-dioxolane-2-spiro-1'-cyclohexane]plat inum (II) in dogsD K Kim, Y B Cho, H T Kim, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|June 30, 2015
Effectiveness of anatomic criteria for predicting parotid tumour locationJ Y Kim, H C Yang, S Lee, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Antitumor activity of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2- isopropyl-1,3-dioxolane]platinum(II), a new platinum analogue, as an anticancer agentD K Kim, H T Kim, Y B Cho, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Pharmacokinetics and antitumor activity of a new platinum compound, cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1, 3- dioxolane]platinum(II), as determined by ex vivo pharmacodynamicsD K Kim, H T Kim, J H Tai, et al.
Journal of Medicinal Chemistry|May 13, 1994
Synthesis and antitumor activity of a series of [2-substituted-4,5-bis(aminomethyl)-1,3-dioxolane]platinum(II) complexesD K Kim, G Kim, J Gam, et al.
International Journal of Colorectal Disease|August 9, 2008
Local recurrence after curative resection in patients with colon and rectal cancersH R Yun, L J Lee, J H Park, et al.
International Journal of Colorectal Disease|September 18, 2008
Double primary malignancy in colorectal cancer patients--MSI is the useful marker for predicting double primary tumorsH R Yun, L J Yi, Y K Cho, et al.
The American Journal of Chinese Medicine|January 16, 2002
Effect of SKI 306X, a new herbal anti-arthritic agent, in patients with osteoarthritis of the knee: a double-blind placebo controlled studyY B Jung, K J Roh, J A Jung, et al.
Cancer Chemotherapy and Pharmacology|January 27, 1998
Influence of exposure and infusion times on the cytotoxicity and pharmacokinetics of cis-malonato[(4R, 5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3-dioxolane]platinum(II) H T Kim, D K Kim, Y B Cho, et al.
Cancer|April 13, 2001
A Phase I study of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-1,3-dioxolane] platinum(II) in patients with advanced malignanciesN K Kim, T Y Kim, S G Shin, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Anticancer Research|May 1, 1996
Pharmacokinetics of a new platinum compound, cis-(glycolato-O,O) [(4R,5R)-4,5-bis(aminomethyl)-1,3-dioxolane-2-spiro-1'-cyclohexane]plat inum (II) in dogsD K Kim, Y B Cho, H T Kim, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|June 30, 2015
Effectiveness of anatomic criteria for predicting parotid tumour locationJ Y Kim, H C Yang, S Lee, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Antitumor activity of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2- isopropyl-1,3-dioxolane]platinum(II), a new platinum analogue, as an anticancer agentD K Kim, H T Kim, Y B Cho, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Pharmacokinetics and antitumor activity of a new platinum compound, cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1, 3- dioxolane]platinum(II), as determined by ex vivo pharmacodynamicsD K Kim, H T Kim, J H Tai, et al.
Journal of Medicinal Chemistry|May 13, 1994
Synthesis and antitumor activity of a series of [2-substituted-4,5-bis(aminomethyl)-1,3-dioxolane]platinum(II) complexesD K Kim, G Kim, J Gam, et al.
International Journal of Colorectal Disease|August 9, 2008
Local recurrence after curative resection in patients with colon and rectal cancersH R Yun, L J Lee, J H Park, et al.
International Journal of Colorectal Disease|September 18, 2008
Double primary malignancy in colorectal cancer patients--MSI is the useful marker for predicting double primary tumorsH R Yun, L J Yi, Y K Cho, et al.
The American Journal of Chinese Medicine|January 16, 2002
Effect of SKI 306X, a new herbal anti-arthritic agent, in patients with osteoarthritis of the knee: a double-blind placebo controlled studyY B Jung, K J Roh, J A Jung, et al.
Cancer Chemotherapy and Pharmacology|January 27, 1998
Influence of exposure and infusion times on the cytotoxicity and pharmacokinetics of cis-malonato[(4R, 5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3-dioxolane]platinum(II) H T Kim, D K Kim, Y B Cho, et al.
Cancer|April 13, 2001
A Phase I study of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-1,3-dioxolane] platinum(II) in patients with advanced malignanciesN K Kim, T Y Kim, S G Shin, et al.
Pageof 4